MHRA GPvP Report: Areas with Critical Findings in Risk Management

The Medicines and Healthcare products Regulatory Agency (MHRA) Good Pharmacovigilance Practice (GPvP) inspectorate in the United Kingdom recently published their latest inspection metrics for the period from April 2019 to March 2020.

All critical findings were in the area of risk management, which is quite consistent with the previously published results, specifically:
▪ 3 in relation to maintenance of reference safety information
▪ 1 in relation to implementation of additional risk minimization measures
▪ 1 in relation to management of additional pharmacovigilance activities in Part III of the risk management plan (RMP)

Ref: Medicines and Healthcare products Regulatory Agency. Pharmacovigilance inspection metrics report, April 2019-March 2020. Published February 26, 2021. Accessed April 5, 2021.

Contact us to assist with all areas of risk management in your business: 877-477-0977 or

#mhra #pharmacovigilance #inspectionreadiness

The Right Partner. The Right Resource. Contact Us